Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine · Delayed Price · Currency is JOD 3.620
+0.020 (0.56%)
At close: Jan 13, 2026
PEX:BJP Balance Sheet
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.13 | 1.02 | 0.55 | 0.7 | 1.09 | 0.85 |
Trading Asset Securities | 0.36 | 0.38 | - | - | - | - |
Cash & Short-Term Investments | 1.49 | 1.4 | 0.55 | 0.7 | 1.09 | 0.85 |
Cash Growth | -22.50% | 153.05% | -20.65% | -36.01% | 27.79% | 497.38% |
Accounts Receivable | 7.93 | 7.27 | 5.8 | 4.41 | 5.39 | 5.07 |
Other Receivables | - | 0 | 0.01 | 0 | 0 | 0.01 |
Receivables | 7.93 | 7.27 | 5.81 | 4.41 | 5.39 | 5.08 |
Inventory | 4.37 | 4.07 | 3.46 | 3.21 | 2.88 | 3.1 |
Prepaid Expenses | - | 0.06 | 0.05 | 0.05 | 0.08 | 0.11 |
Other Current Assets | 0.62 | 0.62 | 0.93 | 0.78 | 0.45 | 0.6 |
Total Current Assets | 14.41 | 13.41 | 10.8 | 9.15 | 9.89 | 9.74 |
Property, Plant & Equipment | 10.99 | 10.45 | 9.1 | 9.1 | 9.21 | 9.9 |
Total Assets | 25.4 | 23.86 | 19.9 | 18.25 | 19.1 | 19.65 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.43 | 0.96 | 0.67 | 0.59 | 1.19 | 1.19 |
Accrued Expenses | - | 0.37 | 0.25 | 0.23 | 0.5 | 0.55 |
Short-Term Debt | 0.83 | 0.62 | 1.19 | 0.23 | 0.75 | 1.53 |
Current Portion of Long-Term Debt | - | - | 0.26 | 0.42 | 0.41 | 0.65 |
Current Income Taxes Payable | 0.05 | 0.34 | 0.61 | 0.5 | 0.56 | 0.48 |
Other Current Liabilities | 0.64 | 0.13 | 0.09 | 0.08 | 0.66 | 0.65 |
Total Current Liabilities | 2.94 | 2.41 | 3.07 | 2.05 | 4.06 | 5.03 |
Long-Term Debt | - | - | - | 0.28 | 0.67 | 1.15 |
Long-Term Unearned Revenue | - | - | - | - | 0.01 | 0.03 |
Pension & Post-Retirement Benefits | 2.02 | 1.75 | 1.4 | 1.33 | 1.16 | 0.99 |
Total Liabilities | 4.95 | 4.16 | 4.47 | 3.66 | 5.9 | 7.2 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 7 | 7 | 7 | 7 | 7 | 7 |
Retained Earnings | 9.42 | 9.95 | 8.05 | 7.03 | 5.9 | 4.61 |
Comprehensive Income & Other | 4.03 | 2.75 | 0.38 | 0.56 | 0.3 | 0.83 |
Shareholders' Equity | 20.45 | 19.7 | 15.43 | 14.59 | 13.2 | 12.45 |
Total Liabilities & Equity | 25.4 | 23.86 | 19.9 | 18.25 | 19.1 | 19.65 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.83 | 0.62 | 1.45 | 0.93 | 1.83 | 3.32 |
Net Cash (Debt) | 0.66 | 0.78 | -0.9 | -0.24 | -0.74 | -2.47 |
Net Cash Growth | -64.36% | - | - | - | - | - |
Net Cash Per Share | 0.09 | 0.11 | -0.13 | -0.03 | -0.11 | -0.35 |
Filing Date Shares Outstanding | 6.97 | 7 | 7 | 7 | 7 | 7 |
Total Common Shares Outstanding | 6.97 | 7 | 7 | 7 | 7 | 7 |
Working Capital | 11.47 | 11 | 7.73 | 7.1 | 5.83 | 4.71 |
Book Value Per Share | 2.93 | 2.81 | 2.20 | 2.08 | 1.89 | 1.78 |
Tangible Book Value | 20.45 | 19.7 | 15.43 | 14.59 | 13.2 | 12.45 |
Tangible Book Value Per Share | 2.93 | 2.81 | 2.20 | 2.08 | 1.89 | 1.78 |
Land | - | - | - | - | - | 6.12 |
Buildings | - | 8.45 | 6.89 | 6.61 | 6.15 | - |
Machinery | - | 17.12 | 14.46 | 14.2 | 13.44 | 13.08 |
Construction In Progress | - | 0.23 | 0.23 | 0.17 | 0.45 | 0.6 |